Eric Owusu Obeng

Dr. Eric Owusu Obeng

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EOEric Owusu Obeng
Eric Owusu Obeng
IRIsabella Rusciano
Isabella Rusciano
MMMaria Vittoria Marvi
Maria Vittoria Marvi
AFAntonietta Fazio
Antonietta Fazio
SRstefano ratti
stefano ratti
Lucio CoccoLucio Cocco
Lucio Cocco
Phosphoinositides (PI) form just a minor portion of the total phospholipid content in cells but are significantly involved in cancer development and progression. In several cancer types, phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3] and phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] play significant roles in regulating survival, proliferation, invasion, and growth of cancer cells. Phosphoinositide-specific phospholipase C (PLC) catalyze the generation of the essential second messengers diacylglycerol (DAG) and inositol 1,4,5 trisphosphate (InsP3) by hydrolyzing PtdIns(4,5)P2. DAG and InsP3 regulate Protein Kinase C (PKC) activation and the release of calcium ions (Ca2+) into the cytosol, respectively. This event leads to the control of several important biological processes implicated in cancer. PLCs have been extensively studied in cancer but their regulatory roles in the oncogenic process are not fully understood. This review aims to provide up-to-date knowledge on the involvement of PLCs in cancer. We focus specifically on PLCβ, PLCγ, PLCδ, and PLCε isoforms due to the numerous evidence of their involvement in various cancer types.

Verified
Journal Article
Open access
PDF file
GRGIULIA RAMAZZOTTI
GIULIA RAMAZZOTTI
SRstefano ratti
stefano ratti
RFRoberta Fiume
Roberta Fiume
MFMatilde Yung Follo
Matilde Yung Follo
ABAnna Maria Billi
Anna Maria Billi
Irene FaenzaIrene Faenza
Irene Faenza
Stem cells are undifferentiated cells that can give rise to several different cell types and can self-renew. Given their ability to differentiate into different lineages, stem cells retain huge therapeutic potential for regenerative medicine. Therefore, the understanding of the signaling pathways involved in stem cell pluripotency maintenance and differentiation has a paramount importance in order to understand these biological processes and to develop therapeutic strategies. In this review, we focus on phosphoinositide 3 kinase (PI3K) since its signaling pathway regulates many cellular processes, such as cell growth, proliferation, survival, and cellular transformation. Precisely, in human stem cells, the PI3K cascade is involved in different processes from pluripotency and induced pluripotent stem cell (iPSC) reprogramming to mesenchymal and oral mesenchymal differentiation, through different and interconnected mechanisms.

Verified
Journal Article
Open access
PDF file
AFAntonietta Fazio
Antonietta Fazio
EOEric Owusu Obeng
Eric Owusu Obeng
IRIsabella Rusciano
Isabella Rusciano
MMMaria Vittoria Marvi
Maria Vittoria Marvi
MZMatteo Zoli
Matteo Zoli
SRstefano ratti
stefano ratti
An increasing number of reports suggests a significant involvement of the phosphoinositide (PI) cycle in cancer development and progression. Diacylglycerol kinases (DGKs) are very active in the PI cycle. They are a family of ten members that convert diacylglycerol (DAG) into phosphatidic acid (PA), two-second messengers with versatile cellular functions. Notably, some DGK isoforms, such as DGKα, have been reported to possess promising therapeutic potential in cancer therapy. However, further studies are needed in order to better comprehend their involvement in cancer. In this review, we highlight that DGKs are an essential component of the PI cycle that localize within several subcellular compartments, including the nucleus and plasma membrane, together with their PI substrates and that they are involved in mediating major cancer cell mechanisms such as growth and metastasis. DGKs control cancer cell survival, proliferation, and angiogenesis by regulating Akt/mTOR and MAPK/ERK pathways. In addition, some DGKs control cancer cell migration by regulating the activities of the Rho GTPases Rac1 and RhoA.

1 January 2021 in Advances in Biological Regulation
Verified
Journal Article
Closed access
IRIsabella Rusciano
Isabella Rusciano
MMMaria Vittoria Marvi
Maria Vittoria Marvi
EOEric Owusu Obeng
Eric Owusu Obeng
SMSara Mongiorgi
Sara Mongiorgi
GRGIULIA RAMAZZOTTI
GIULIA RAMAZZOTTI
SRstefano ratti
stefano ratti

1 January 2020 in Advances in Biological Regulation
Verified
Journal Article
Closed access
ARAna Raquel Ramos
Ana Raquel Ramos
SGSomadri Ghosh
Somadri Ghosh
TSTara Suhel
Tara Suhel
CCClément Chevalier
Clément Chevalier
EOEric Owusu Obeng
Eric Owusu Obeng
CEChristophe Erneux
Christophe Erneux

12 March 2020 in Cells
Verified
Journal Article
Open access
PDF file
JXJie Xian
Jie Xian
EOEric Owusu Obeng
Eric Owusu Obeng
SRstefano ratti
stefano ratti
IRIsabella Rusciano
Isabella Rusciano
MMMaria Vittoria Marvi
Maria Vittoria Marvi
MFMatilde Yung Follo
Matilde Yung Follo
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematological malignancies characterized by peripheral blood cytopenia and abnormal myeloproliferation, as well as a variable risk of evolution into acute myeloid leukemia (AML). The nucleus is a highly organized organelle with several distinct domains where nuclear inositides localize to mediate essential cellular events. Nuclear inositides play a critical role in the modulation of erythropoiesis or myelopoiesis. Here, we briefly review the nuclear structure, the localization of inositides and their metabolic enzymes in subnuclear compartments, and the molecular aspects of nuclear inositides in MDS.